Skip to main content
. Author manuscript; available in PMC: 2015 Jan 30.
Published in final edited form as: Pharmacopsychiatry. 2012 Jun 14;46(1):29–34. doi: 10.1055/s-0032-1314843

Table 4.

BDNF release by anti-inflammatory agents and antidepressants.

A
10 min 60 min
control 13.2 ± 3.1 (12)− 15.9 ± 3.0 (12)−

citalopram 10.9 ± 4.0 (8) ns 18.4 ± 1.9 (6) ns

ibuprofen 16.0 ± 5.4 (6) ns 18.7 ± 6.3 (7) ns

indomethacin 18.9 ± 3.9 (8) ns 21.6 ± 6.0 (8) ns

paroxetine 17.1 ± 4.3 (9) ns 20.2 ± 2.9 (7) ns

sertraline 13.4 ± 2.8 (8) ns 25.4 ± 5.8 (7) ns
B
10 min 60 min
control + Ca2+ 72.2±10.8 (9)− 95.2±12.2 (9)−

citalopram + Ca2+ 67.3±7.7 (6) ns 95.3±14.5 (5) ns

ibuprofen + Ca2+ 43.8±16.3 (5)* 57.2±21.3 (5)**

indomethacin + Ca2+ 76.6±13.7 (6) ns 88.5± 17.6 (6) ns

paroxetine + Ca2+ 58.9±20.2 (6) ns 92.0 ±24.8 (4) ns

sertraline + Ca2+ 77.8 ±16.4 (6) ns 85.7 ±17.9 (4) ns

Platelets were isolated from rat blood. Anti-inflammatory drugs or antidepressants without (A) or with (B) Ca2+ were added and platelets were incubated at 37 °C for 10 or 60 min. Supernatants were collected and BDNF was analyzed by ELISA. Values are given as mean ± SEM % of total. The number of analyzed slices is given in parenthesis. Statistical analysis was performed by one-way ANOVA with a Fisher LSD post-hoc test.

*

p < 0.05

**

p < 0.01; ns, not significant